Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 5 (3%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114097 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-03-16 | 2022-04-06 | 156780 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-05-04 | 2022-08-05 | 159990 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-08-29 | 2023-01-17 | 168148 |
| PATADAY | 0.2% | SOLUTION | Resolved | 2019-05-07 | 2019-06-19 | 83364 |
| ARZERRA | 100MG | SOLUTION | Resolved | 2017-03-23 | 2018-10-17 | 4096 |
| ARZERRA | 1000MG | SOLUTION | Resolved | 2017-03-23 | 2018-09-27 | 4093 |
| SANDOSTATIN | 50MCG | SOLUTION | Resolved | 2022-11-22 | 2023-02-11 | 175439 |
| SANDOSTATIN | 50MCG | SOLUTION | Anticipated shortage | 2024-03-22 | 2024-03-22 | 223074 |
| SANDOSTATIN | 100MCG | SOLUTION | Resolved | 2022-05-06 | 2023-02-11 | 160174 |
| SANDOSTATIN | 100MCG | SOLUTION | Actual shortage | 2024-02-06 | 2024-03-21 | 218624 |
| IZBA | 0.003% | SOLUTION | Resolved | 2022-04-11 | 2022-05-11 | 158479 |
| IZBA | 0.003% | SOLUTION | Resolved | 2022-09-29 | 2023-01-06 | 170482 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-01-20 | 2020-03-31 | 103745 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114100 |
| LUTATHERA | 370MBq | SOLUTION | Resolved | 2022-05-06 | 2022-06-14 | 160113 |
| DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Resolved | 2023-04-28 | 2023-10-04 | 191074 |
| DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Actual shortage | 2024-03-21 | 2024-05-07 | 222962 |
| XOLAIR | 150MG | POWDER FOR SOLUTION | Resolved | 2023-11-22 | 2024-04-10 | 211221 |
| XOLAIR | 150MG | POWDER FOR SOLUTION | Anticipated shortage | 2024-04-10 | 2024-04-10 | 224781 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |